CHRS Operating Expenses

Coherus Oncology Inc · Operating Expenses

CHRS logo

CHRS Operating Expenses

Latest reported$42.40M
CHRS Quarterly Operating Expenses ($712.00K → $42.40M)
High-resolution chart · PNG

CHRS operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
42,396,000
43,766,000
53,687,000
49,117,000
51,329,000
49,335,000
62,532,000
56,420,000
55,933,000
68,656,000
75,862,000
73,871,000
68,411,000
83,307,000
82,643,000
90,639,000
92,887,000
131,670,000
100,814,000
94,010,000
95,111,000
242,883,000
82,321,000
70,835,000
60,225,000
68,457,000
71,018,000
53,396,000
55,339,000
51,472,000
60,502,000
56,972,000
44,910,000
42,032,000
46,466,000
56,615,000
58,033,000
72,578,000
74,304,000
78,218,000
76,804,000
76,711,000
62,405,000
78,384,000
65,761,000
42,558,000
33,053,000
22,475,000
22,903,000
17,357,000
11,719,000
7,289,000
749,000
712,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.